EP2635282A1 - Compositions and methods for treating myelofibrosis,https://www.google.com/patents/EP2635282A1?cl=3Den
CN101829223A - Traditional Chinese medicine composition for ...,https://www.google.com/patents/CN101829223A?cl=en
Compositions and methods for treating myelofibrosis - Google Patents,https://www.google.com/patents/WO2012061833A1
US20110229558A1 - Agent for treating myelofibrosis - Google Patents,https://www.google.com/patents/US20110229558?cl=ja
WO2016207405A1 - Prognostic marker for myeloproliferative ...,https://www.google.com/patents/WO2016207405A1?cl=de
CA2819560A1 - Treatment of jak2-mediated conditions - Google ...,https://www.google.com/patents/CA2819560A1
WO2016168612A1 - Methods for treating myeloproliferative ...,https://www.google.com/patents/WO2016168612A1?cl=en
WO2017141942A1 - Medicinal composition for treating fibrosis ...,https://www.google.com/patents/WO2017141942A1?cl=en
EP1554015A1 - Treatment of amm - Google Patents,https://www.google.com/patents/EP1554015A1?cl=zh
WO1995029694A1 - Collagen hydrolysis accelerator - Google Patents,https://www.google.com/patents/WO1995029694A1?cl=de29
